Key facts: EUROBANK S.A. 9M Profit €1.16B; Eurolife Growth & €0.0599 Div

EUROBANK S.A. reported 9-month net profit of €1.16B, up 12.4% YoY, with net interest income of €2.06B and fees of €630M. Organic loan growth was €3.8B, and insurance growth was led by Eurolife. The company declared an interim dividend of €0.0599 per share, payable on Nov 26.

Original reporting
Published Oct 29, 2026, 7:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 7:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Key facts: EUROBANK S.A. 9M Profit €1.16B; Eurolife Growth & €0.0599 Div — source image
Decision brief

The 30-second read

Med
01

Why it matters

The earnings beat may attract short‑term buying, but broader macro risks remain.

02

Market read

Positive earnings for a mid‑cap European bank, offering modest trading opportunity.

03

What to watch

Potential headwinds from regional economic slowdown could temper gains.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Eurobank's 9‑month earnings highlight growth in net interest income and loan portfolio.

Market effects

Banking sector may see slight uplift from a strong regional earnings report.

Greek market could benefit from Eurobank's positive results.

Limited to European banking investors.

Counterpoint

If the profit growth is already priced in, the stock may face limited upside.

Key entities

  • Eurobank S.A.

    Greek banking group reporting earnings.

Related articles

HighAI 8/10

Eurobank builds on its Cyprus presence as group earnings climb

Eurobank reported a €1.16bn net profit for the first nine months of 2026, with its Cyprus operations contributing €367m. The bank's international revenue reached €1.23bn, with Cyprus being the largest contributor. Operating expenses and impairment losses were also detailed. The group's balance sheet expanded, and an interim dividend was declared. Eurobank also provided macroeconomic assumptions for Cyprus, projecting GDP growth and other key indicators.

HighAI 8/10

Eurobank 9M 2026 slides: profit surges 14%, NII guidance raised to 9%

Eurobank reported a 14.3% year-over-year increase in adjusted net profit to €1,209 million for the first nine months of 2026. The bank raised its full-year net interest income growth guidance to 9% from 7%. Shares rose 3.05% to $2.03. Key drivers include margin expansion, loan growth, and improving asset quality in Greece, Cyprus, and Bulgaria. The acquisition of Eurolife Life Insurance is expected to boost fee income.

MedAI 9/10

Eurobank completes Eurolife Life acquisition

Eurobank has finalized the acquisition of an 80% stake in Eurolife Life Insurance from Fairfax Financial Holdings for €813m. The Greek bank now fully owns Eurolife Life. Eurobank also reported a 14.3% rise in adjusted net profit to €1.21bn for the first nine months of 2026, with core income up 9.7% to €2.70bn. The bank announced an interim dividend of €0.0599 per share.

MedAI 8/10

Key facts: EUROBANK S.A. 9M Net €1.16B; NPE 2.4%, Div €0.0599

EUROBANK S.A. reported a 9-month net profit of €1.16B, up 12.4% YoY. Net interest income rose 8.7% to €2.06B, and fees increased 13% to €630M. Loans grew 10.5% to €3.8B. The NPE ratio improved to 2.4%, and an interim dividend of €0.0599 per share will be paid on November 26, according to Reuters.

Med

Morgan Stanley sees upside for Alpha Bank and Eurobank

Morgan Stanley reiterated its positive outlook on Greek banks, with Alpha Bank and Eurobank as top picks. It expects Q3 results to meet market expectations, with net interest income slightly above forecasts. For 2027-2028, it forecasts higher net interest income, potentially leading to upward EPS revisions. Price targets: Alpha Bank €5.50 (28.9% upside), Eurobank €5.40 (21.6% upside).